<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="40167">5-Iodotubercidin</z:chebi> is a potent inhibitor of the enzyme <z:chebi fb="3" ids="16335">adenosine</z:chebi> kinase </plain></SENT>
<SENT sid="1" pm="."><plain>It has a recognized ability to enhance interstitial fluid levels of the cerebroprotective <z:chebi fb="0" ids="35584">purine</z:chebi>, <z:chebi fb="3" ids="16335">adenosine</z:chebi>, in the hypoxic brain, and an <z:chebi fb="0" ids="35623">anticonvulsant</z:chebi> action, which is thought to be a consequence of its ability to increase extracellular <z:chebi fb="3" ids="16335">adenosine</z:chebi> levels </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="0" ids="40167">5-Iodotubercidin</z:chebi> (1 mg/kg, i.p.) was therefore tested for its ability to reduce cerebral ischemic injury in a gerbil model </plain></SENT>
<SENT sid="3" pm="."><plain>Unanesthetized gerbils were subjected to a 5 min period of bilateral carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> and then maintained in an environmental chamber at 30 degrees C for 5 hr to counteract the <z:hpo ids='HP_0002045'>hypothermia</z:hpo>-inducing action of <z:chebi fb="0" ids="40167">5-iodotubercidin</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>As estimated from the extent of the increases in locomotor activity and the magnitude of hippocampal CAI layer pyramidal cell loss, <z:chebi fb="0" ids="40167">5-iodotubercidin</z:chebi> (1 mg/kg) failed to have a cerebroprotective effect against ischemic injury </plain></SENT>
</text></document>